All persons or entities that purchased or otherwise acquired Amylyx Pharmaceuticals, Inc. (“Amylyx” or the “Company”) securities during the period from November 11, 2022, through November 8, 2023, inclusive.
Preliminarily Approved
November 10, 2022 - February 06, 2024
September 10, 2026
August 11, 2026
Strategic Claims Services
600 N. Jackson St., Suite 205
P.O. Box 230
Media, PA 19063
+1 866-274-4004
[email protected]
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.